SCHEMBL2269657

SCHEMBL2269657

Cc1cccc(C(=O)Nc2cc(-c3cccc(Cl)c3)ccc2C(=O)OC(C)(C)C)c1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.45
HPGD P15428 3/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
NPC1 O15118 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ACLY P53396 3/20 0.41
KCNMA1 Q12791 1/20 0.41
PTGER4 P35408 2/20 0.41
PTGER2 P43116 1/20 0.41
WDR5 P61964 2/20 0.39
TSHR P16473 2/20 0.39
HSD17B10 Q99714 2/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39
KDM4E B2RXH2 1/20 0.39
POLB P06746 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2276321 0.85 ACLY (0.56) NPC1ACLYKCNMA1PTGER4PTGER2
SCHEMBL2275605 0.84 ACLY (0.53) ALDH1A1HPGDMEN1KMT2ANPC1
SCHEMBL2272065 0.84 ALDH1A1 (0.40) ALDH1A1HPGDMEN1KMT2ANPC1
SCHEMBL12117544 0.83 MEN1 (0.51) ALDH1A1HPGDMEN1KMT2AACLY
SCHEMBL2272608 0.82 ALDH1A1 (0.47) ALDH1A1HPGDMEN1KMT2ANPC1
SCHEMBL2272448 0.81 CYP1A2 (0.47) ALDH1A1HPGDMEN1KMT2ANPC1
SCHEMBL14429486 0.81 KCNMA1 (0.44) ALDH1A1HPGDMEN1KMT2ANPC1
SCHEMBL2273301 0.80 MAPT (0.40) ALDH1A1HPGDMEN1KMT2ANPC1
SCHEMBL12117652 0.79 HDAC1 (0.48) ALDH1A1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL12117713 0.79 ALDH1A1 (0.50) ALDH1A1HPGDMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
EP-1820795-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP26, MMP11 ALDH1A1 645/4885HPGD 274/4885MEN1 3105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.